Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
China · Delayed Price · Currency is CNY 3.260
+0.040 (1.24%)
Sep 7, 2026, 3:04 PM CST
SHE:002589 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 7,167 | 7,296 | 7,967 | 8,034 | 12,311 | 21,060 |
Revenue Growth | -4.16% | -8.42% | -0.84% | -34.74% | -41.54% | -22.67% |
Gross Profit Gross Profit Growth | 781.4 | 769.9 | 870.93 | 822.06 | 1,628 | 3,745 |
Operating Income Operating Income Growth | 137.93 | 72.26 | 19.97 | -84.27 | -108.72 | 813.41 |
Net Income Net Income Growth | 9.04 | 16.07 | 12.29 | 20.32 | -1,831 | 131.18 |
Earnings Per Share EPS Growth | 0.01 | 0.01 | 0.01 | 0.01 | -1.24 | 0.09 |
EPS Growth | 90.93% | 0% | -25.93% | - | - | -50.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Drugs and Devices Drugs and Devices Growth | 7,002 | 7,126 | 7,787 | 7,957 | 12,211 | 20,954 |
Sales of Mobile Medical Software and Services Sales of Mobile Medical Software and Services Growth | 42.96 | 45.75 | 68.41 | 52.34 | 77.2 | 86.88 |
Lease Lease Growth | 28.22 | 28.56 | 24.13 | 25.42 | 22.72 | 19.14 |
Sales of Other Products Sales of Other Products Growth | 94.09 | 95.1 | 86.82 | - | - | - |
Total Total Growth | 7,167 | 7,296 | 7,967 | 8,034 | 12,311 | 21,060 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 5,752 | 3,745 | 4,984 | 5,061 | 5,340 | 4,579 |
Total Debt Total Debt Growth | 5,178 | 4,605 | 6,584 | 6,824 | 4,004 | 4,544 |
Net Cash (Debt) Net Cash Growth | 573.9 | -860.3 | -1,600 | -1,764 | 1,336 | 34.82 |
Net Cash Growth | - | - | - | - | 3737.34% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.36 | -0.54 | -1.30 | -1.17 | 0.90 | 0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -5.41 | 13.76 | 160.79 | 82.47 | 523.07 | 442.95 |
Capital Expenditures CapEx Growth | 32.23 | -26.82 | -111.57 | -298.38 | -170.96 | -461.09 |
Free Cash Flow Free Cash Flow Growth | 26.82 | -13.06 | 49.22 | -215.92 | 352.11 | -18.13 |
Free Cash Flow Growth | -50.30% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 10.90% | 10.55% | 10.93% | 10.23% | 13.23% | 17.78% |
Operating Margin | 1.92% | 0.99% | 0.25% | -1.05% | -0.88% | 3.86% |
Pretax Margin | 0.78% | 0.04% | 0.38% | -1.69% | -14.16% | 2.21% |
Profit Margin | 0.13% | 0.22% | 0.15% | 0.25% | -14.87% | 0.62% |
FCF Margin | 0.37% | -0.18% | 0.62% | -2.69% | 2.86% | -0.09% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.002 | 0.002 | 0.011 | 0.013 | - | 0.009 |
Dividend Per Share Growth | -81.82% | -81.82% | -15.38% | - | - | -50.00% |
Dividend Yield | 0.06% | 0.06% | 0.37% | 0.40% | - | 0.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 530.13 | 297.39 | 361.52 | 242.17 | - | 44.83 |
Forward PE | - | 8.02 | 8.02 | 8.02 | 8.02 | 8.45 |
P/FCF Ratio | 178.66 | - | 90.29 | - | 17.51 | - |
PS Ratio | 0.67 | 0.66 | 0.56 | 0.61 | 0.50 | 0.28 |